
The country's drugs regulator on Sunday approved Oxford-AstraZeneca's Covishield and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3om0jFu
via
IFTTT
0 comments:
Post a Comment